Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2340272A pandemic influenza vaccine in children 3-9 years
NCT01014091Phase 3Terminated
- Sponsor
- GSK
- Start
- Dec 2009
- Primary completion
- Jan 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Q-Pan H1N1 in influenza, sponsored by GSK. Started Dec 2009; status: terminated.
02
Drugs
Q-Pan H1N1
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01014091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01014091.